Quarterly report pursuant to Section 13 or 15(d)

Initial Public Offering - Summary of Reconciliation of Common Stock Reflected in the Balance Sheet (Detail)

v3.22.2.2
Initial Public Offering - Summary of Reconciliation of Common Stock Reflected in the Balance Sheet (Detail) - USD ($)
3 Months Ended 7 Months Ended 9 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Schedule of Reconciliation of Common Stock Reflected in the Balance Sheet [Line Items]            
Gross proceeds from IPO         $ 225,400,000 $ 0
Proceeds allocated to Public Warrants         (11,700,000) 0
Accretion of carrying value to redemption value   $ 21,374,977 $ 796,360 $ 63,680 $ 21,374,977 860,040
Contingently redeemable common stock $ 235,460,040 234,600,000 235,460,040     235,460,040
Common Stock [Member]            
Schedule of Reconciliation of Common Stock Reflected in the Balance Sheet [Line Items]            
Gross proceeds from IPO   234,600,000        
Proceeds allocated to Public Warrants   (8,740,000)        
Common stock issuance costs   (12,634,977)        
Accretion of carrying value to redemption value 860,040          
Contingently redeemable common stock $ 235,460,040 $ 234,600,000 $ 235,460,040     $ 235,460,040